Live from the NIH registry
Studies recruiting near Lansing right now
Top 25 of 172 recruiting studies, sorted by proximity — each links to its official registry page
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
McLaren Greater Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Sparrow Hospital — Lansing, Michigan (1.3 mi)
· Sponsor: SWOG Cancer Research Network
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Wright & Filippis x Ottobock.care — Lansing, Michigan (1.3 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,900 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: NRG Oncology
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis
Phase 2
Interventional 48 participants sought
Michigan State University — East Lansing, Michigan (4.2 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Multiple conditions
Phase 2
Interventional 98 participants sought
Karmanos Cancer Institute at McLaren Greater Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: NRG Oncology
Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device
Alzheimer s Disease, MCI Conversion to Dementia
N/A
Observational 1,000 participants sought
Memorial Healthcare Hospital — Owosso, Michigan (27.6 mi)
· Sponsor: Neurogen Biomarking LLC
Engaging College Students in Developing and Testing a Video-based Intervention for HPV Vaccination Promotion
N/A - Healthy Subjects
N/A
Interventional 123 participants sought
Michigan State University — East Lansing, Michigan (4.2 mi)
· Sponsor: Michigan State University
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
Active Rheumatoid Arthritis
Phase 2
Interventional 180 participants sought
Great Lakes Center of Rheumatology — Lansing, Michigan (1.3 mi)
· Sponsor: Elevara Medicines Limited
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Michigan State University — East Lansing, Michigan (4.2 mi)
· Sponsor: National Cancer Institute (NCI)
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
Uncontrolled Gout
Phase 3
Interventional 270 participants sought
June DO PC — Lansing, Michigan (1.3 mi)
· Sponsor: Amgen
Patient Retrospective Outcomes (PRO)
Chronic Pain
N/A
Observational 15,000 participants sought
Michigan Orthopedic Center — Lansing, Michigan (1.3 mi)
· Sponsor: Boston Scientific Corporation
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Phase 3
Interventional 1,295 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Heart Failure
Phase 3
Interventional 6,712 participants sought
Sparrow Clinical Research Institute — Lansing, Michigan (1.3 mi)
· Sponsor: Boehringer Ingelheim
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus
Phase 2
Interventional 405 participants sought
June DO, PC — Lansing, Michigan (1.3 mi)
· Sponsor: Boehringer Ingelheim
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Generalized Myasthenia Gravis
Phase 3
Interventional 231 participants sought
Site Number - 1005 — East Lansing, Michigan (4.2 mi)
· Sponsor: Immunovant Sciences GmbH
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Obesity, Heart Failure
Phase 3
Interventional 5,610 participants sought
University Of Michigan — Lansing, Michigan (1.3 mi)
· Sponsor: Novo Nordisk A/S
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: SWOG Cancer Research Network
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 2,400 participants sought
Karmanos Cancer Institute at McLaren Greater Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: SWOG Cancer Research Network
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
McLaren Greater Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: Novo Nordisk A/S
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Owosso, Michigan (27.6 mi)
· Sponsor: TG Therapeutics, Inc.
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Treating Chronic Cervicogenic Head and Neck Pain
Cervicogenic Headache, Neck Pain, Posterior
Phase 1, Phase 2
Interventional 30 participants sought
Michigan State University — East Lansing, Michigan (4.2 mi)
· Sponsor: Michigan State University
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,500 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: NRG Oncology